RxDoctor Payments Data

Miles Hamm

Physician Assistant · Clermont, FLNPI 1205564960

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.8% of the total across 227 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 41 manufacturers, the largest accounting for just 12.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,548, 7.5 times the $340 reported in 2022. Among physician assistant clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,976in general payments, 2019–2025

Across 227 payments — averaging $26.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$756
  • AbbVie$753
  • Johnson & Johnson$616
  • Takeda Pharmaceuticals U.S.A., Inc.$343
  • Eisai Inc.$338
  • Axsome Therapeutics, Inc.$229
  • plus $3K from 35 others

What the payments were for

  • Food & beverage$5,90299%
  • Education$751%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,976 in reported general payments places this provider in the 90th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida →

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl12$19,221
TrintellixVortioxetine Hydrobromide19$10,206
Atomoxetine Hcl12$515
Bupropion XlBupropion Hcl24$438
Risperidone31$377
Buspirone Hcl19$325
Escitalopram Oxalate59$321
Quetiapine Fumarate57$304
Benztropine Mesylate15$304
Lamotrigine15$174
Trazodone Hcl35$157
Hydroxyzine Hcl15$149
Duloxetine Hcl13$110
Sertraline Hcl28$99
Hydroxyzine Pamoate23$85

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$753$19,22112 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$343$10,20619 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Clermont

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →